Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Coupling/pathway control diagram"

From Bioblast
Β 
(7 intermediate revisions by 2 users not shown)
Line 2: Line 2:
|abbr=CPCD
|abbr=CPCD
|description=[[File:SUIT-nomenclature.jpg|300px|right|SUIT protocols]]
|description=[[File:SUIT-nomenclature.jpg|300px|right|SUIT protocols]]
'''Coupling/pathway control diagrams''' illustrate the respiratory '''states''' obtained step-by-step in substrate-uncoupler-inhibitor titrations in a [[SUIT protocol]]. Each step (to the next state) is defined by an initial state and a [[metabolic control variable]], ''X''. The respiratory states are shown by boxes. ''X'' is usually the titrated substance in a SUIT protocol. If ''X'' ([[ADP]], [[uncoupler]]s, or inhibitors of the [[phosphorylation system]], e.g. oligomycin) exerts '''coupling control''', then a transition is induced between two [[coupling control state]]s. If ''X'' (fuel substrates, e.g. pyruvate and succinate, or [[ETS]] inhibitors, e.g. rotenone) exerts '''pathway control''', then a transition is induced between two [[pathway control state]]s. The type of metabolic control (''X'') is shown by arrows linking two respiratory states, with vertical arrows indicating coupling control, and horizontal arrows indicating pathway control. [[Marks in DatLab]] define the section of an experimental trace in a given [[respiratory state]] (steady state). [[Events in DatLab]] define the titration of ''X'' inducing a transition in the SUIT protocol. The specific sequence of coupling control and pathway control steps defines the [[SUIT protocol pattern]]. The coupling/pathway control diagrams define the [[categories of SUIT protocols]] (see Figure).
'''Coupling/pathway control diagrams''' illustrate the respiratory '''states''' obtained step-by-step in substrate-uncoupler-inhibitor titrations in a [[SUIT protocol]]. Each step (to the next state) is defined by an initial state and a [[metabolic control variable]], ''X''. The respiratory states are shown by boxes. ''X'' is usually the titrated substance in a SUIT protocol. If ''X'' ([[ADP]], [[uncoupler]]s, or inhibitors of the [[phosphorylation system]], e.g. oligomycin) exerts '''coupling control''', then a transition is induced between two [[coupling-control state]]s. If ''X'' (fuel substrates, e.g. pyruvate and succinate, or [[Electron transfer pathway]] inhibitors, e.g. rotenone) exerts '''pathway control''', then a transition is induced between two [[Electron-transfer-pathway state]]s. The type of metabolic control (''X'') is shown by arrows linking two respiratory states, with vertical arrows indicating coupling control, and horizontal arrows indicating pathway control. [[Marks - DatLab |Marks]] define the section of an experimental trace in a given [[respiratory state]] (steady state). [[Events - DatLab |Events]] define the titration of ''X'' inducing a transition in the SUIT protocol. The specific sequence of coupling control and pathway control steps defines the [[SUIT protocol pattern]]. The coupling/pathway control diagrams define the [[categories of SUIT protocols]] (see Figure).
|info=[[Gnaiger 2014 MitoPathways]]
|info=[[Gnaiger 2020 BEC MitoPathways]]
}}
{{MitoPedia concepts
|mitopedia concept=MiP concept, SUIT concept
}}
}}
Β  Communicated by [[Gnaiger Erich]] 2016-06-07, edited 2016-10-31.
Β  Communicated by [[Gnaiger Erich]] 2016-06-07, edited 2016-10-31.
Line 14: Line 11:


::::Β» [[Categories of SUIT protocols]]
::::Β» [[Categories of SUIT protocols]]
{{MitoPedia concepts
|mitopedia concept=MiP concept, SUIT concept
}}

Latest revision as of 20:03, 1 January 2021


high-resolution terminology - matching measurements at high-resolution


Coupling/pathway control diagram

Description

SUIT protocols

Coupling/pathway control diagrams illustrate the respiratory states obtained step-by-step in substrate-uncoupler-inhibitor titrations in a SUIT protocol. Each step (to the next state) is defined by an initial state and a metabolic control variable, X. The respiratory states are shown by boxes. X is usually the titrated substance in a SUIT protocol. If X (ADP, uncouplers, or inhibitors of the phosphorylation system, e.g. oligomycin) exerts coupling control, then a transition is induced between two coupling-control states. If X (fuel substrates, e.g. pyruvate and succinate, or Electron transfer pathway inhibitors, e.g. rotenone) exerts pathway control, then a transition is induced between two Electron-transfer-pathway states. The type of metabolic control (X) is shown by arrows linking two respiratory states, with vertical arrows indicating coupling control, and horizontal arrows indicating pathway control. Marks define the section of an experimental trace in a given respiratory state (steady state). Events define the titration of X inducing a transition in the SUIT protocol. The specific sequence of coupling control and pathway control steps defines the SUIT protocol pattern. The coupling/pathway control diagrams define the categories of SUIT protocols (see Figure).

Abbreviation: CPCD

Reference: Gnaiger 2020 BEC MitoPathways

Communicated by Gnaiger Erich 2016-06-07, edited 2016-10-31.

See also

Β» MitoPedia: SUIT concept
Β» Categories of SUIT protocols


MitoPedia concepts: MiP concept, SUIT concept